NCT04359238View on ClinicalTrials.gov

activeDCM - Interventional Clinical Trial of Individualized Activity and Exercise Programs to Improve Outcome in Dilated Cardiomyopathy Guided by Longitudinal Biosensing With Apple Watch

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

April 1, 2024

Study Completion Date

June 1, 2024

Conditions
Cardiomyopathy, DilatedHeart Failure
Interventions
BEHAVIORAL

Individualized excercise

The participants in the intervention group carry out regularly endurance and strength exercises.

Trial Locations (1)

69115

RECRUITING

Department III of Internal Medicine, University Hospital Heidelberg, Heidelberg

Sponsors
All Listed Sponsors
collaborator

Apple Inc.

INDUSTRY

collaborator

The German Heart Foundation

OTHER

collaborator

Informatics for Life

UNKNOWN

collaborator

e-Cardiology

UNKNOWN

collaborator

German Cardiac Society

OTHER

collaborator

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

OTHER

lead

University Hospital Heidelberg

OTHER

NCT04359238 - activeDCM - Interventional Clinical Trial of Individualized Activity and Exercise Programs to Improve Outcome in Dilated Cardiomyopathy Guided by Longitudinal Biosensing With Apple Watch | Biotech Hunter | Biotech Hunter